// App-Quantinova.ai

431 : Circulating fibroblast growth factor 21 (FGF21) as diagnostic and prognostic biomarker in renal cancer

Researchers

Presenter

  • Maria Elena Knott

Principal Investigators

  • Jose Nicolas Minatta

  • Lucia Roulet

  • Guillermo Gueglio

  • Leonardo Pasik

  • Stella Maris Ranuncolo

  • Myriam Nunez

  • Lydia Ines Puricelli

  • Mariana Silvia De Lorenzo

Medical Centers

  • Instituto de Oncologia Angel H. Roffo, Buenos Aires, Argentina

  • Hospital Durand, Buenos Aires, Argentina

  • Facultad de Farmacia y Bioquimica, University of Buenos Aires (UBA), Argentina

  • Rutgers, The State University of New Jersey, Newark, NJ.

Locations

  • United States

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

  • Solid malignancies

  • Renal cell carcinoma

  • Diabetes

  • Obesity

Biomarkers

  • X-Ray Repair Cross Complementing 1

  • Body mass index

Drug/Treatment

  • FGF-21

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved